How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Backing founders who can raise late-stage capital
Alex recounts the Loyal (dog longevity) story, showing founder-market fit and how early bets scaled into $60M+ funding and FDA milestones.
Transcript
Play full episode
